Developing of granulomatous thyroiditis during etanercept therapy
- 29 November 2008
- journal article
- case report
- Published by Springer Nature in Clinical Rheumatology
- Vol. 28 (1) , 17-19
Abstract
We describe a 32-year-old man who developed granulomatous thyroiditis (GT) during etanercept therapy for rheumatoid arthritis (RA). Fever and thyroid pain developed 8 months after administration of etanercept. Noncaseating epithelioid cell granulomas consistent with GT were detected in a thyroid biopsy. Tissue staining and cultures for bacteria, mycobacterium, and fungus were all negative. Etanercept therapy was withdrawn and steroids regime was indicated with clinical and laboratory improvement. A month after, the patient developed hypothyroidism and recurrence of RA. A year after, the patient is asymptomatic with rituximab, methotrexate, and levothyroxine therapy. We report a case of GT probably in an etanercept-induced granulomatous reaction context.Keywords
This publication has 8 references indexed in Scilit:
- Development of Sarcoidosis during Etanercept TherapyInternal Medicine, 2008
- Pulmonary Sarcoidosis Associated with Etanercept TherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Development of sarcoidosis in etanercept-treated rheumatoid arthritis patientsClinical Rheumatology, 2007
- Development of sarcoidosis during etanercept therapyArthritis Care & Research, 2006
- Granulomatous lung disease occurring during etanercept treatmentArthritis & Rheumatism, 2005
- Treatment of Sarcoidosis With InfliximabChest, 2005
- Pulmonary granulomas after tumour necrosis factor alpha antagonist therapyThorax, 2003
- Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor AntagonistsThe Journal of Pharmacology and Experimental Therapeutics, 2002